129 related articles for article (PubMed ID: 33352323)
21. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
22. Thrombolytic Therapy for Pulmonary Embolism in COVID 19 ARDS: A Case Series.
Yelle S
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062801
[TBL] [Abstract][Full Text] [Related]
23. Intravenous thrombolysis for acute ischaemic stroke during COVID-19 pandemic in Wuhan, China: a multicentre, retrospective cohort study.
Zhou Y; Hong C; Chang J; Xia Y; Jin H; Li Y; Mao L; Wang Y; Zhang L; Pan C; Hu J; Huang M; Wang D; Chen S; Hu B
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):226-228. PubMed ID: 33115934
[No Abstract] [Full Text] [Related]
24. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
[TBL] [Abstract][Full Text] [Related]
25. Likelihood of amyloid formation in COVID-19-induced ARDS.
Sinha N; Thakur AK
Trends Microbiol; 2021 Nov; 29(11):967-969. PubMed ID: 33795156
[TBL] [Abstract][Full Text] [Related]
26. Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS.
Morales-Quinteros L; Neto AS; Artigas A; Blanch L; Botta M; Kaufman DA; Schultz MJ; Tsonas AM; Paulus F; Bos LD;
Crit Care; 2021 May; 25(1):171. PubMed ID: 34001222
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
Front Immunol; 2021; 12():664209. PubMed ID: 34054832
[TBL] [Abstract][Full Text] [Related]
28. Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism.
Oliynyk OV; Rorat M; Solyarik SO; Lukianchuk VA; Dubrov SO; Guryanov VH; Oliynyk YV; Yaroslavskaya SM; Szalast R; Barg W
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515199
[TBL] [Abstract][Full Text] [Related]
29. Acute cor pulmonale in Covid-19 related acute respiratory distress syndrome.
Cavaleiro P; Masi P; Bagate F; d'Humières T; Mekontso Dessap A
Crit Care; 2021 Sep; 25(1):346. PubMed ID: 34563245
[No Abstract] [Full Text] [Related]
30. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature.
D'Abramo A; Lepore L; Palazzolo C; Barreca F; Liuzzi G; Lalle E; Nicastri E
Int J Infect Dis; 2020 Aug; 97():236-239. PubMed ID: 32565366
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary embolism among critically ill patients with ARDS due to COVID-19.
Soumagne T; Winiszewski H; Besch G; Mahr N; Senot T; Costa P; Grillet F; Behr J; Mouhat B; Mourey G; Fournel A; Meneveau N; Samain E; Capellier G; Piton G; Pili-Floury S
Respir Med Res; 2020 Nov; 78():100789. PubMed ID: 33022510
[No Abstract] [Full Text] [Related]
32. Methadone as a rescue drug for difficult-to-sedate critically ill patients suffering from ARDS related to SARS-CoV-2 infection.
Fernández-Tobar R; Chamorro-Jambrina C; Pérez-Torres M; Castiñeiras-Amor B; Alcántara-Carmona S; Romera-Ortega MA
Med Intensiva (Engl Ed); 2022 May; 46(5):279-281. PubMed ID: 35292199
[No Abstract] [Full Text] [Related]
33. Ventilatory weaning and early rehabilitation in COVID-19-related acute respiratory distress syndrome: the experience at Locarno hospital, canton of Ticino, Switzerland.
Forni R; Besana T; Amitrano A; Voinea C; Ogna A
Swiss Med Wkly; 2020 Nov; 150():w20397. PubMed ID: 33180953
[No Abstract] [Full Text] [Related]
34. Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.
Hanidziar D; Robson SC
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L12-L16. PubMed ID: 33050737
[TBL] [Abstract][Full Text] [Related]
35. Histopathological features in fatal COVID-19 acute respiratory distress syndrome.
Merdji H; Mayeur S; Schenck M; Oulehri W; Clere-Jehl R; Cunat S; Herbrecht JE; Janssen-Langenstein R; Nicolae A; Helms J; Meziani F; Chenard MP;
Med Intensiva (Engl Ed); 2021; 45(5):261-270. PubMed ID: 34059216
[TBL] [Abstract][Full Text] [Related]
36. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
37. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Altschuler EL; Kast RE
Med Hypotheses; 2020 Aug; 141():109774. PubMed ID: 32344275
[No Abstract] [Full Text] [Related]
38. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
Speer G; Somogyi P
Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
[TBL] [Abstract][Full Text] [Related]
39. Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.
Cascella M; Mauro I; De Blasio E; Crispo A; Del Gaudio A; Bimonte S; Cuomo A; Ascierto PA
Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32727107
[TBL] [Abstract][Full Text] [Related]
40. Role of Tissue Plasminogen Activator for Diffuse Pulmonary Microemboli in Coronavirus Disease 2019 Patient.
Ghia S; Bhatt H; Lazar M
J Cardiothorac Vasc Anesth; 2021 Jul; 35(7):2137-2139. PubMed ID: 32962933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
